Chapter/Section Purchase

1 Study Coverage
1.1 Drug-Device Combination Products Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Others
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug-Device Combination Products Sales Estimates and Forecasts 2017-2028
2.2 Global Drug-Device Combination Products Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug-Device Combination Products Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug-Device Combination Products Sales by Region
2.4.1 Global Drug-Device Combination Products Sales by Region (2017-2022)
2.4.2 Global Sales Drug-Device Combination Products by Region (2023-2028)
2.5 Global Drug-Device Combination Products Revenue by Region
2.5.1 Global Drug-Device Combination Products Revenue by Region (2017-2022)
2.5.2 Global Drug-Device Combination Products Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug-Device Combination Products Sales by Manufacturers
3.1.1 Global Top Drug-Device Combination Products Manufacturers by Sales (2017-2022)
3.1.2 Global Drug-Device Combination Products Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Device Combination Products in 2021
3.2 Global Drug-Device Combination Products Revenue by Manufacturers
3.2.1 Global Drug-Device Combination Products Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug-Device Combination Products Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2021
3.3 Global Drug-Device Combination Products Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug-Device Combination Products Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Device Combination Products Sales by Type
4.1.1 Global Drug-Device Combination Products Historical Sales by Type (2017-2022)
4.1.2 Global Drug-Device Combination Products Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug-Device Combination Products Sales Market Share by Type (2017-2028)
4.2 Global Drug-Device Combination Products Revenue by Type
4.2.1 Global Drug-Device Combination Products Historical Revenue by Type (2017-2022)
4.2.2 Global Drug-Device Combination Products Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug-Device Combination Products Revenue Market Share by Type (2017-2028)
4.3 Global Drug-Device Combination Products Price by Type
4.3.1 Global Drug-Device Combination Products Price by Type (2017-2022)
4.3.2 Global Drug-Device Combination Products Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug-Device Combination Products Sales by Application
5.1.1 Global Drug-Device Combination Products Historical Sales by Application (2017-2022)
5.1.2 Global Drug-Device Combination Products Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug-Device Combination Products Sales Market Share by Application (2017-2028)
5.2 Global Drug-Device Combination Products Revenue by Application
5.2.1 Global Drug-Device Combination Products Historical Revenue by Application (2017-2022)
5.2.2 Global Drug-Device Combination Products Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug-Device Combination Products Revenue Market Share by Application (2017-2028)
5.3 Global Drug-Device Combination Products Price by Application
5.3.1 Global Drug-Device Combination Products Price by Application (2017-2022)
5.3.2 Global Drug-Device Combination Products Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug-Device Combination Products Market Size by Type
6.1.1 North America Drug-Device Combination Products Sales by Type (2017-2028)
6.1.2 North America Drug-Device Combination Products Revenue by Type (2017-2028)
6.2 North America Drug-Device Combination Products Market Size by Application
6.2.1 North America Drug-Device Combination Products Sales by Application (2017-2028)
6.2.2 North America Drug-Device Combination Products Revenue by Application (2017-2028)
6.3 North America Drug-Device Combination Products Market Size by Country
6.3.1 North America Drug-Device Combination Products Sales by Country (2017-2028)
6.3.2 North America Drug-Device Combination Products Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size by Type
7.1.1 Europe Drug-Device Combination Products Sales by Type (2017-2028)
7.1.2 Europe Drug-Device Combination Products Revenue by Type (2017-2028)
7.2 Europe Drug-Device Combination Products Market Size by Application
7.2.1 Europe Drug-Device Combination Products Sales by Application (2017-2028)
7.2.2 Europe Drug-Device Combination Products Revenue by Application (2017-2028)
7.3 Europe Drug-Device Combination Products Market Size by Country
7.3.1 Europe Drug-Device Combination Products Sales by Country (2017-2028)
7.3.2 Europe Drug-Device Combination Products Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug-Device Combination Products Market Size by Type
8.1.1 Asia Pacific Drug-Device Combination Products Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug-Device Combination Products Revenue by Type (2017-2028)
8.2 Asia Pacific Drug-Device Combination Products Market Size by Application
8.2.1 Asia Pacific Drug-Device Combination Products Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug-Device Combination Products Revenue by Application (2017-2028)
8.3 Asia Pacific Drug-Device Combination Products Market Size by Region
8.3.1 Asia Pacific Drug-Device Combination Products Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug-Device Combination Products Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size by Type
9.1.1 Latin America Drug-Device Combination Products Sales by Type (2017-2028)
9.1.2 Latin America Drug-Device Combination Products Revenue by Type (2017-2028)
9.2 Latin America Drug-Device Combination Products Market Size by Application
9.2.1 Latin America Drug-Device Combination Products Sales by Application (2017-2028)
9.2.2 Latin America Drug-Device Combination Products Revenue by Application (2017-2028)
9.3 Latin America Drug-Device Combination Products Market Size by Country
9.3.1 Latin America Drug-Device Combination Products Sales by Country (2017-2028)
9.3.2 Latin America Drug-Device Combination Products Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug-Device Combination Products Market Size by Type
10.1.1 Middle East and Africa Drug-Device Combination Products Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug-Device Combination Products Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug-Device Combination Products Market Size by Application
10.2.1 Middle East and Africa Drug-Device Combination Products Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug-Device Combination Products Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug-Device Combination Products Market Size by Country
10.3.1 Middle East and Africa Drug-Device Combination Products Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug-Device Combination Products Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Polyzen
11.1.1 Polyzen Corporation Information
11.1.2 Polyzen Overview
11.1.3 Polyzen Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Polyzen Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Polyzen Recent Developments
11.2 Kaleo
11.2.1 Kaleo Corporation Information
11.2.2 Kaleo Overview
11.2.3 Kaleo Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Kaleo Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kaleo Recent Developments
11.3 Terumo Corporation
11.3.1 Terumo Corporation Corporation Information
11.3.2 Terumo Corporation Overview
11.3.3 Terumo Corporation Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Terumo Corporation Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Terumo Corporation Recent Developments
11.4 Nuventra
11.4.1 Nuventra Corporation Information
11.4.2 Nuventra Overview
11.4.3 Nuventra Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nuventra Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nuventra Recent Developments
11.5 Antares
11.5.1 Antares Corporation Information
11.5.2 Antares Overview
11.5.3 Antares Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Antares Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Antares Recent Developments
11.6 Novus Therapeutics
11.6.1 Novus Therapeutics Corporation Information
11.6.2 Novus Therapeutics Overview
11.6.3 Novus Therapeutics Drug-Device Combination Products Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novus Therapeutics Drug-Device Combination Products Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novus Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Device Combination Products Industry Chain Analysis
12.2 Drug-Device Combination Products Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Device Combination Products Production Mode & Process
12.4 Drug-Device Combination Products Sales and Marketing
12.4.1 Drug-Device Combination Products Sales Channels
12.4.2 Drug-Device Combination Products Distributors
12.5 Drug-Device Combination Products Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug-Device Combination Products Industry Trends
13.2 Drug-Device Combination Products Market Drivers
13.3 Drug-Device Combination Products Market Challenges
13.4 Drug-Device Combination Products Market Restraints
14 Key Findings in The Global Drug-Device Combination Products Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer